AQUESTIVE CLASS ACTION LAWSUIT: A METICULOUSLY AUTHORITATIVE INVESTOR GUIDE [2026]
If you purchased or acquired shares of Aquestive stock between June 16, 2025 and January 8, 2026, and suffered a loss you are most likely a member of the class. Call Timothy L. Miles for more information about the lead plaintiff process or any other questions you may have at no charge. 855-846-6529 or [email protected]
Introduction to the Aquestive Class Action Lawsuit
- Who is Affected by the Aquestive class action lawsuit? All purchasers or acquirers of Aquestive Therapeutics, Inc. (NASDAQ: AQST) securities between June 16, 2025 and January 8, 2026, inclusive (the “Class Period”).
- The Problem: The Aquestive lawsuit alleges the defendant made false and misleading statements driving the stock price artificially up until the truth emerged and the stock plummeted and shareholders who purchased during the relevant time period and suffered a loss are entitle to damages
- Your Action: You may be eligible to recover your losses in a Aquestive lawsuit
- Deadline to Lead: The deadline to apply to be Lead Plaintiff in the is Aquestive lawsuit is May 4, 2026.
Key Aspects of Securities Fraud Class Actions
The fraud: This involves a company or its executives intentionally making false or misleading statements to manipulate the stock market. This can include concealing important information that, if known, would have affected an investor’s decision to buy, sell, or hold the stock.
- The class period: This is the timeframe during which the alleged fraud took place. It typically starts when the misleading information is released and ends when the truth is fully disclosed to the public, often leading to a significant drop in the stock price. The class period in the Aquestive Lawsuit is June 16, 2025 and January 8, 2026.
- Investor eligibility: To be included, you must have purchased or sold the company’s securities during the class period and suffered an economic loss.
- Lead plaintiff: A court-approved lead plaintiff represents the entire class, oversees the Aquestive Lawsuit and has the authority to approve settlements on behalf of all class members.
- Legal basis: These lawsuits are based on federal and state securities laws, such as the Securities Act of 1933 and the Securities Exchange Act of 1934.
- Benefits: Class actions give individual investors leverage against large companies and allow them to share the costs of litigation through a contingency-fee arrangement, meaning the lawyers are paid only if the class wins.
- Participation: Investors who are eligible to join the class do not have to join and can “opt out” to pursue their own individual lawsuit, though this requires hiring and paying a private attorney.
How it Works
- A lawsuit is initiated by one or more investors, called the “lead plaintiffs,” on behalf of a larger group of investors, or the “class”.
- The “class period” is defined as the specific timeframe during which the alleged fraudulent activity took place. Only those who bought or sold the security during this period are eligible to participate.
- A lead plaintiff is appointed to represent the class. Under the Private Securities Litigation Reform Act (PSLRA), the court will typically appoint the investor with the largest financial interest in the outcome of the case.
- The case is litigated, which may include a lengthy discovery phase for gathering evidence.
- The case can be settled or go to trial. Most class actions are resolved through settlements, which can include cash or stock paid into a common fund for the class. The lead plaintiff and class counsel approve any settlement before it is finalized.
Common Types of Misconduct
- Securities fraud class actions can arise from various types of misconduct by a company, its officers, or others involved in the sale of its securities, including:
- Making false or misleading statements in SEC filings, prospectuses, or earnings announcements.
- Overstating a company’s revenues or profits through fraudulent or “creative” accounting.
- Failing to disclose material information that would significantly alter an investor’s view.
- Engaging in market manipulation to artificially inflate or deflate a security’s price.
What Plaintiffs Must Prove
To succeed in a federal securities fraud class action, plaintiffs must prove several elements:
- Material misstatement or omission: The company made a false or misleading statement, or failed to disclose a material fact.
- Scienter: The defendant acted with an intent to deceive, manipulate, or defraud.
- Reliance: The plaintiff relied on the misstatement or omission when buying or selling the security. For publicly traded securities, this can be proven through the “fraud-on-the-market” theory, which presumes the market price reflects all public, material information.
- Economic loss: The plaintiff suffered a financial loss.
- Loss causation: The company’s misstatement or omission directly caused the plaintiff’s loss, often demonstrated by a stock price drop after the truth is revealed in a “corrective disclosure“
Benefits for Investors
- Participating in a class action allows investors to pool their resources, which offers leverage they would not have in an individual lawsuit against a large corporation.
- The collective approach also makes it more efficient and cost-effective to pursue legal action, especially for smaller investors.
How to Get Involved
- If you bought a security during the alleged class period and suffered a loss, you are generally automatically included in the class. You don’t have to take any action unless you want to file a claim for recovery later.
- You may be notified of a class action by mail if you are an eligible class member.
- You may be able to become a lead plaintiff by applying within 60 days of the first lawsuit being announced.
- If you believe you may have a claim, you can contact a securities class action law firm for guidance.
Allegations in the Aquestive Class Action Lawsuit
Aquestive operates as a pharmaceutical company.
The Aquestive class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that:
- Aquestive created the false impression that Aquestive was on track to receive approval for Aquestive’s New Drug Application (“NDA”) for Anaphylm by the January 31, 2026 Prescription Drug User Fee Act (“PDUFA”) date;
- The U.S. Food and Drug Administration (“FDA”) identified deficiencies with Aquestive’s NDA for Anaphylm precluding labeling discussions and post-marketing commitments; and
- In order for the FDA to grant approval for any NDA, any deficiencies must be remedied, therefore the launch of Anaphylm was delayed, indicating that Aquestive failed to obtain approval for Anaphylm by the PDUFA date.
The Aquestive lawsuit alleges that on January 9, 2026, Aquestive disclosed that it was in receipt of an FDA letter that “identified deficiencies in the [Anaphylm] NDA that preclude discussion of labeling and post-marketing commitments at this time.”
On this news, the price of Aquestive stock fell more than 37%, according to the Aquestive lawsuit.
Options Available to Shareholders
- Do Nothing (Remain a Class Member): This is the most common option. If you take no action, you automatically remain a member of the class.
- Exclude Yourself (Opt-Out): You have the absolute right to exclude yourself from the class action. This is often referred to as “opting out.”
- How to Exclude Yourself (Opt-Out): The process for opting out is not available immediately, but only when the class has been formally certified and a settlement or trial is imminent.
- Wait for the Class Notice: If a settlement is reached, the court will approve a Notice of Proposed Settlement that is mailed to all known class members.
- Review the Notice: This document will contain specific, formal instructions on how to exclude yourself from the settlement.
- Submit a Written Request: You must draft and mail a letter stating clearly that you wish to be excluded from the class action, and include all identifying information (name, address, shares sold, etc.).
- Meet the Deadline: Your exclusion request must be postmarked by the deadline in the Notice.
Rights of Investors
Investors affected by the Aquestive class action lawsuit possess specific rights that they can exercise. Understanding these rights is vital for anyone considering involvement in the lawsuit.
Right to Information
- Investors have the right to receive accurate and timely updates regarding the Aquestive lawsuit.
- This includes information on the case’s progress, potential settlements, and any necessary actions they may need to undertake.
Right to Participate
- Affected investors have the right to join the Aquestive lawsuit.
- This allows them to collaborate with other investors in seeking compensation for their losses without the burden of filing individual lawsuits.
Right to Legal Representation
- Investors can seek legal counsel to navigate the complexities of the Aquestive lawsuit.
- Legal professionals can provide guidance and support throughout the process.
- If you suffered substantial losses and wish to serve as lead plaintiff of the Aquestive lawsuit or just have general questions about you rights as a shareholder, please contact attorney Timothy L. Miles of the Law Offices of Timothy L. Miles, at no cost, by calling 855/846-6529 or via e-mail at [email protected].
The Benefits of Serving as the Lead Plaintiff
Serving as a Lead Plaintiff has several advantages and important benefits.
- First, a Lead Plaintiff is able to negotiate more competitive attorney fees and reduce other litigation costs by actively monitoring the class counsel.
- Second, Lead Plaintiff has the benefit of being able to manage the litigation primarily by overseeing and monitoring the progress of the action and the efforts of counsel, and being able to review and comment on important filings and other documents pertaining to the prosecution of the action.
- Third, there is no financial risk in serving as a Lead Plaintiff because Lead Counsel advances all costs and expenses incurred in the prosecution of the case and will be reimbursed only if there is a successful settlement or judgment recovery on behalf of the class.
- Fourth, Lead Plaintiff has the benefit involved and active in all negotiations relating to any settlement.
- Finally, Lead Plaintiffs that continue owning the stock of the defendant will enjoy the long-term benefits from governance reform resulting from the litigation. Successful lawsuits with large punishments might have a stronger disciplining effect on a defendant’s management and raise awareness of the importance of corporate
Lead Plaintiff Information
The Lead Plaintiff is the person or entity appointed by the court to represent the entire class in a securities class action or shareholder lawsuit.
This role involves a fiduciary duty to act in the best interests of all class members, making significant decisions throughout the litigation process.
To be appointed, a shareholder typically must show they have the largest financial interest in the relief sought and are capable of adequately protecting the class.
The deadline to move for appointment as Lead Plaintiff is strictly 60 days from the date the first class action notice is published.
The Responsibilities of the Lead Plaintiff
- The Lead Plaintifff may select and retain counsel of their choosing to represent the class which importantly includes negotiating the contingent fees Lead Counsel will receive in the event of a settlement or judgment.
- Responsible for managing the litigation principally by overseeing and monitoring the progress of the action and the efforts of Lead Counsel.
- Lead Plaintiff will review, comment, and make suggestions on important court filings and other related documents pertaining to the prosecution of the class action.
- Lead Plaintiff will also participate in discovery, including gathering information that may involve answering interrogatories, producing documents and other evidence, and their sworn deposition taken before a court reporter.
- The Lead Plaintiff also attends hearings, trials, and other court proceedings.
- The Lead Plaintiff is to consult with the Lead Counsel about any possible settlements.
- Once settlement discussions began, the Lead Plaintiff will have an opportunity to be active in all negotiations.
- This may include attending mediations and being active in all aspects of the settlement.
- The Lead Plaintiff must approve any settlement before it is presented to a court.
Key Facts About Securities Class Action Lawsuits
- Common Causes: Lawsuits usually claim violations of the Securities Exchange Act of 1934 (Section 10(b) and Rule 10b-5) due to misleading information in SEC filings, press releases, or earnings calls.
- The “Class Period”: This is the time frame in which the stock was allegedly inflated. Investors must have bought shares during this period to be part of the class.
- Settlements and Trials: Less than 1% of cases go to trial, with most being dismissed or settled. In 2024, there were 88 settlements totaling roughly
- Median Recoveries: In 2024, the median settlement was roughly a million, a slight decrease from 2023 but still high compared to historical data.
- Lead Plaintiffs and Opt-Outs: Often, large institutional investors act as “lead plaintiffs.” Individual investors are generally notified and can participate or “opt out” to pursue their own, separate litigation.
- Statute of Limitations: Federal securities fraud cases generally have a limitation period of up to five years from the date of the alleged fraud.
Common Legal Claims
- Section 10(b) / Rule 10b-5: The most common claim, rrequiring proof of “scienter” (intent to defraud) and loss causation.
- Section 11: Used for misleading statements in registration documents; it has a lower burden of proof as it does not require showing intent to defraud.
- Common Allegations: Misrepresenting financial health, failing to disclose material weaknesses, or making false forward-looking performance
Typical Litigation Process
- Filing & Lead Plaintiff: After an initial complaint, the court appoints a Lead Plaintiff, typically the investor with the largest financial interest.
- Motion to Dismiss: Defendants almost always file a motion to dismiss; in 2025, 62% of decided motions were granted by the courts.
- Class Certification: The court must officially certify the group as a “class” before the case can proceed on behalf of all affected investors.
- Discovery: A lengthy phase where parties exchange documents and testimony; this is often the most burdensome stage for defendant companies.
- Summary Judgement: Defendants argue that the facts after discovery do not state a claim for violation of the federal securities laws.
- Resolution: The vast majority of cases that are not dismissed end in a settlement rather than a trial. The median time to settlement is approximately 3.3 years.
- Court Approval and Notice: The court approves the settlement if it finds it is fair, adequate and reasonable and orders notice to be give to the class to participate in the settlement, object to the settlement or opt-out of the settlements.
- Administration. The Court appoints a third-party to administrate the settlement proceeds to class members.
When Is the Lead Plaintiff Deadline:
Under the Private Securities Litigation Reform Act (PSLRA), the plaintiff who files the first complaint has 20 days to publish the required notice of the pendency of the action.
- Notice Publication: Not later than 20 days after the complaint is filed, the plaintiff in the Aquestive Lawsuit must publish a notice advising other sharehoders of the pendency of the action.
- Lead Plaintiff Motion Deadline: Not later than 60 days after the date the notice is published.
- Court Consideration: The court must consider motions to consolidate and appoint a lead plaintiff no later than 90 days after the notice is published.
The Eligibility Criteria for Lead Plaintiff Appointment in the Enphase lawsuit
To be eligible for appointment as the lead plaintiff in the Aquestive class action lawsuit, an investor must meet the following criteria:
- Securities Acquisition: The investor must have purchased or acquired of Aquestive common stock between June 16, 2025 and January 8, 2026.
- Financial Losses: The investor must have suffered financial losses as a direct result of the alleged securities fraud perpetrated by Aquestive and its executives.
- Typicality and Adequacy: The investor’s legal claims must be typical of those asserted on behalf of the class, and they must demonstrate their ability to adequately represent the interests of the entire class through experience, resources, and the absence of conflicts of interest.
It is crucial to note that both domestic and international investors who meet these criteria are eligible to seek appointment as the lead plaintiff in the class Aquestive lawsuit as courts have consistently recognized the rights of non-U.S. investors in securities class actions.
Contingency Fee Agreements: No Cost to Hire a Lawyer
- No Fee: It does not cost anything to hire a lawyer if you are eligible for an Aquestive lawsuit. We take all cases on a contingency basis which means we do not get paid unless we win or settle your case.
- Talk with a Lawyer Free of Charge: A lawyer can explain the process of an Aquestive lawsuit and answer any questions you may have free of charge.
The Settlement Process in the Aquestive Class Action Lawsuit
- Reaching a Tentative Agreement
- Negotiation: Attorneys for the lead plaintiff and defendants negotiate terms, often through mediation.
- MOU: Once they agree on a figure, they draft a Memorandum of Understanding (MOU) or a formal Stipulation of Settlement.
- Plan of Allocation: The parties develop a formula to determine how much each investor will receive based on their “recognized loss” during the class period.
- Preliminary Court Approval
- Initial Review: The judge reviews the settlement to ensure it is “fair, reasonable, and adequate” for the class members.
- Preliminary Order: If satisfied, the judge issues an order that schedules a final hearing and authorizes notice to the class.
- Class Notice and Claims Filing
- Notice: A court-appointed Claims Administrator sends notices to potential class members via mail or publication.
- Filing a Claim: To receive a payout, eligible investors must submit a Proof of Claim form with documentation of their stock trades (e.g., brokerage statements).
- Opt-Outs/Objections: Class members have a deadline to “opt out” (to sue individually) or “object” to the settlement terms in court.
- Final Approval and Distribution
- Final Fairness Hearing: The court holds a hearing to consider any objections and decide whether to grant final approval.
- Judgment: Once the judge signs the final judgment, the settlement becomes legally binding, and the lawsuit is dismissed.
- Payout: The Claims Administrator verifies all claims and distributes checks or direct deposits.
- Timeline: Payouts typically begin 9 to 12 months after final approval due to the complexity of auditing thousands of claims.
- Pro-Rata: Funds are usually distributed on a pro-rata basis, meaning your share depends on your specific losses relative to the total pool.
Advanced Red Flags and Warning Signs
One red flag to watch for is aggressive accounting practices, such as recognizing revenue prematurely or delaying expense recognition. These tactics can artificially inflate earnings and create a misleading picture of a company’s financial health. Investors should also scrutinize non-recurring or one-time items, as companies may use these as a means to smooth earnings and hide underlying issues.
- Corporate governance deficiencies often correlate with increased fraud risk. Warning signs include:
- Domineering management that discourages questions or dissent from board members
- Lack of independent directors or audit committee members with insufficient financial expertise
- Frequent changes in key personnel, particularly in financial reporting roles
- Poor communication between management and the board of directors
A pattern of frequent restatements or amendments to financial statements is also cause for concern, as it may indicate a lack of accuracy or transparency in financial reporting. When companies repeatedly revise their previously filed statements, it suggests either incompetence in financial reporting or deliberate manipulation that was later discovered.
Protecting Your Investment Portfolio
- Red Flags: By keeping an eye out for these red flags, investors can better protect themselves against the risks of financial statement fraud and make more informed investment choices. The key lies in combining quantitative analysis of financial metrics with qualitative assessment of management behavior and corporate governance practices.
- Maintain Skepticim: Investors should maintain healthy skepticism when reviewing financial statements, particularly when companies report results that seem too good to be true or inconsistent with industry trends. Regulatory compliance monitoring and awareness of SEC regulations can provide additional layers of protection against fraudulent investments.
- Empowering Investors: Understanding these financial statement fraud risk factors empowers investors to identify potential problems before they result in significant losses, ultimately contributing to more robust and transparent capital markets for all participants.
Frequently Asked Questions About the Aquestive Class Action Lawsuit
What initiated the Aquestive lawsuit?
The Aquestive lawsuit is initiated by investors alleging that Aquestive provided misleading information regarding its financial health and operations, resulting in financial losses.
How can I join the Aquestive lawsuit?
If you purchased shares during the class period and suffered a loss, then you are automatically a member of the Aquestive lawsuit and do not need to do anything at this point unless you are considering moving for lead plaintiff.
What are the potential benefits of a Aquestive lawsuit?
Class action lawsuits like the Aquestive lawsuit allow individual investors to collectively seek justice and compensation, which might be challenging to pursue individually. They also promote corporate accountability.
How long will the Aquestive class action lawsuit take to resolve?
The duration of class action lawsuits can vary significantly, depending on the complexity of the case, legal strategies, and whether settlements are reached. It could take several months to years to resolve the lawsuit.
What is the role of a lead plaintiff in securities class action lawsuist?
A lead plaintiff is responsible for selecting and monitoring lead counsel, responding to discovery requests, providing testimony when needed, reviewing key filings, and participating in settlement negotiations. They act as a fiduciary for the entire class, overseeing the litigation process to ensure the best possible outcome for all class members.
How does the court determine who becomes the lead plaintiff in asecurities class action lawsuit?
The court typically appoints the investor with the largest financial interest in the case as the lead plaintiff, provided they meet the typicality and adequacy requirements of Rule 23. This is based on factors such as total class period purchases, net expenditures, and total losses. The appointed lead plaintiff must be capable of fairly representing the interests of the entire class.
What are the potential benefits of serving as a lead plaintiff?
Serving as a lead plaintiff allows an investor to have a significant influence on the case outcome, including the size and structure of settlements and potential corporate governance reforms. While lead plaintiffs don’t receive extra compensation beyond their pro rata share, their active involvement can help maximize recovery for all class members and promote greater corporate accountability.
Contact Timothy L. Miles Today About a Investor Aquestive Action Lawsuit
The most important thing you need to know is you can call me at no charge if you wish to serve as lead plaintiff of the Aquestive class action lawsuit, or just have general questions about you rights as a shareholder, please contact attorney Timothy L. Miles of the Law Offices of Timothy L. Miles, at no cost, by calling 855/846-6529 or via e-mail at [email protected]. (24/7/365).
Timothy L. Miles, Esq.
Law Offices of Timothy L. Miles
Tapestry at Brentwood Town Center
300 Centerview Dr. #247
Mailbox #1091
Brentwood,TN 37027
Phone: (855) Tim-MLaw (855-846-6529)
Email: [email protected]
Website: www.classactionlawyertn.com
Facebook Linkedin Pinterest youtube
Visit Our Extensive Investor Hub: Learning for Informed Investors
